Infants with Tyrosinemia Type 1: Should phenylalanine be supplemented?-Reference-Cited by-同舟云学术

Infants with Tyrosinemia Type 1: Should phenylalanine be supplemented?

Published:2014 Issue: Volume: Page:117-124
ISSN:2192-8304
Container-title:JIMD Reports
language:
Short-container-title:

Author:

van Vliet Danique,van Dam Esther,van Rijn Margreet,Derks Terry G. J.,Venema-Liefaard Gineke,Hitzert Marrit M.,Lunsing Roelineke J.,Heiner-Fokkema M. Rebecca,van Spronsen Francjan J.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/8904_2014_358

Reference23 articles.

1. Bendadi F, de Koning TJ, Visser G et al (2014) Impaired cognitive functioning in patients with tyrosinemia type I receiving nitisinone. J Pediatr 164:398–401

2. Bruggink JL, Einspieler C, Butcher PR, Stremmelaar EF, Prechtl HF, Bos AF (2009) Quantitative aspects of the early motor repertoire in preterm infants: do they predict minor neurological dysfunction at school age? Early Hum Dev 85:25–36

3. Couce ML, Dalmau J, del Toro M, Pintos-Morell G, Aldamiz-Echevarria L, Spanish Working Group on Tyrosinemia Type 1 (2011) Tyrosinemia type 1 in Spain: mutational analysis, treatment and long-term outcome. Pediatr Int 53:985–989

4. Daly A, Gokmen-Ozel H, MacDonald A, Preece MA, Davies P, Chakrapani A, McKiernan P (2012) Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned? J Hum Nutr Diet 25:111–116

5. De Laet C, Munoz VT, Jaeken J et al (2011) Neuropsychological outcome of NTBC-treated patients with tyrosinaemia type 1. Dev Med Child Neurol 53:962–964

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 12-month, longitudinal, intervention study examining a tablet protein substitute preparation in the management of tyrosinemia;Molecular Genetics and Metabolism Reports;2024-09

2. Inborn Errors of Carbohydrate, Ammonia, Amino Acid, and Organic Acid Metabolism;Avery's Diseases of the Newborn;2024

3. A 12-month, longitudinal, intervention study examining a tablet protein substitute preparation in the management of tyrosinemia.;2023-08-30

4. Biochemical and behavioural profile of NTBC treated Tyrosinemie type 1 mice;Molecular Genetics and Metabolism;2022-09

5. Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway;Journal of Inherited Metabolic Disease;2022-06-30